I will agree with that statement. If 1625 had disappointed(safety/efficacy), I would have felt really bad for anyone holding their stock since it wouldve been chopped in half. Dew is right in surmising that the definition of winner is ambiguous.
INHX runup seemed way overextended. I'm not sure INX-189 will be able to compete or bring any outside interest. They seem somewhat dead in the water to me.